• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 和鼻病毒感染:儿科患者的临床表现、实验室异常和结局是否存在差异?

SARS-CoV-2 and rhinovirus infections: are there differences in clinical presentation, laboratory abnormalities, and outcomes in the pediatric population?

机构信息

Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Instituto da Criança e do Adolescente, Departamento de Pediatria, Unidade de Infectologia Pediátrica, São Paulo, São Paulo, Brazil.

Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Instituto da Criança e do Adolescente, Departamento de Pediatria, Unidade de Emergência Pediátrica, São Paulo, São Paulo, Brazil.

出版信息

Rev Inst Med Trop Sao Paulo. 2022 May 25;64:e34. doi: 10.1590/S1678-9946202264034. eCollection 2022.

DOI:10.1590/S1678-9946202264034
PMID:35648987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9134860/
Abstract

This study aims to assess COVID-19 and other respiratory viruses in pediatric patients. Between April 17 and September 30, 2020, we collected 1,566 respiratory samples from 1,044 symptomatic patients who were younger than 18 years old to assess SARS-CoV-2 infection. Of these, 919 were analyzed for other respiratory pathogens (ORP). Patients with laboratory-confirmed COVID-19 or ORP were included. We evaluated 76 pediatric COVID-19 infections and 157 other respiratory virus infections. Rhinovirus occurred in 132/157 (84%). COVID-19 patients who were significantly older, had more fevers, headaches and pneumonia than those with ORP. The median white blood cell count was lower in patients with SARS-CoV-2 than in those with ORP (6,470 versus 8,170; p=0.02). COVID-19 patients had significantly worse symptoms than those with ORP.

摘要

本研究旨在评估儿童患者中的 COVID-19 和其他呼吸道病毒。在 2020 年 4 月 17 日至 9 月 30 日期间,我们收集了 1044 名年龄小于 18 岁的有症状患者的 1566 份呼吸道样本,以评估 SARS-CoV-2 感染情况。其中,919 份样本用于分析其他呼吸道病原体(ORP)。纳入实验室确诊的 COVID-19 或 ORP 患者。我们评估了 76 例儿科 COVID-19 感染和 157 例其他呼吸道病毒感染。157 例中 132 例(84%)为鼻病毒感染。COVID-19 患者的年龄明显大于 ORP 患者,且发热、头痛和肺炎的发生率也高于 ORP 患者。与 ORP 患者相比,SARS-CoV-2 患者的白细胞计数中位数明显更低(6470 对 8170;p=0.02)。COVID-19 患者的症状明显比 ORP 患者更严重。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/195e/9134860/ec77809f36f8/1678-9946-rimtsp-64-S1678-9946202264034-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/195e/9134860/ec77809f36f8/1678-9946-rimtsp-64-S1678-9946202264034-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/195e/9134860/ec77809f36f8/1678-9946-rimtsp-64-S1678-9946202264034-gf01.jpg

相似文献

1
SARS-CoV-2 and rhinovirus infections: are there differences in clinical presentation, laboratory abnormalities, and outcomes in the pediatric population?SARS-CoV-2 和鼻病毒感染:儿科患者的临床表现、实验室异常和结局是否存在差异?
Rev Inst Med Trop Sao Paulo. 2022 May 25;64:e34. doi: 10.1590/S1678-9946202264034. eCollection 2022.
2
Increased risk of rhinovirus infection in children during the coronavirus disease-19 pandemic.新冠疫情期间儿童感染鼻病毒的风险增加。
Influenza Other Respir Viruses. 2021 Jul;15(4):488-494. doi: 10.1111/irv.12854. Epub 2021 Mar 14.
3
Incidence and Outcome of Coinfections with SARS-CoV-2 and Rhinovirus.SARS-CoV-2 与鼻病毒合并感染的发生率和结局。
Viruses. 2021 Dec 16;13(12):2528. doi: 10.3390/v13122528.
4
Clinical and Laboratory Findings of SARS-CoV-2 Infection in Children Younger than 6 Months Old: Neutropenia is More Common Not Lymphopenia.6 月龄以下儿童新型冠状病毒感染的临床和实验室特征:中性粒细胞减少症比淋巴细胞减少症更常见。
J Trop Pediatr. 2022 Apr 5;68(3). doi: 10.1093/tropej/fmac041.
5
Clinical Outcomes Associated with SARS-CoV-2 Co-Infection with Rhinovirus and Adenovirus in Adults-A Retrospective Matched Cohort Study.与 SARS-CoV-2 感染合并鼻病毒和腺病毒相关的临床结局:一项回顾性匹配队列研究。
Int J Environ Res Public Health. 2022 Dec 30;20(1):646. doi: 10.3390/ijerph20010646.
6
Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.使用完整医院数据的回顾性研究:SARS-CoV-2、流感、RSV 及其他七种呼吸道病毒的临床表型和结局。
Thorax. 2022 Feb;77(2):154-163. doi: 10.1136/thoraxjnl-2021-216949. Epub 2021 Jul 5.
7
Comparison of acute pneumonia caused by SARS-COV-2 and other respiratory viruses in children: a retrospective multi-center cohort study during COVID-19 outbreak.比较 SARS-CoV-2 和其他呼吸道病毒引起的儿童急性肺炎:COVID-19 疫情期间的回顾性多中心队列研究。
Mil Med Res. 2021 Feb 16;8(1):13. doi: 10.1186/s40779-021-00306-7.
8
Diagnostic Efficacy and Tolerability of Molded Plastic Nasopharyngeal Swab (FinSwab) Compared to Flocked Nylon Swab in Detection of SARS-CoV-2 and Other Respiratory Viruses.比较 Molded Plastic Nasopharyngeal Swab(FinSwab)与 Flocked Nylon Swab 对 SARS-CoV-2 和其他呼吸道病毒检测的诊断效果和耐受性。
Microbiol Spectr. 2021 Oct 31;9(2):e0073621. doi: 10.1128/Spectrum.00736-21. Epub 2021 Oct 20.
9
Comparison of Clinical Findings in SARS-CoV-2 with Other Respiratory Viruses in Critically Ill Children during the COVID-19 Pandemic.COVID-19 大流行期间危重症儿童中 SARS-CoV-2 与其他呼吸道病毒的临床特征比较。
J Trop Pediatr. 2021 Dec 8;67(6). doi: 10.1093/tropej/fmab102.
10
Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19.SARS-CoV-2 与其他呼吸道病毒的合并感染和下呼吸道样本用于 COVID-19 诊断的性能。
Int J Infect Dis. 2021 Jan;102:10-13. doi: 10.1016/j.ijid.2020.10.040. Epub 2020 Oct 25.

引用本文的文献

1
Epidemiology, Clinical Significance, and Diagnosis of Respiratory Viruses and Their Co-Infections in the Post-COVID Era.新冠疫情后时代呼吸道病毒及其合并感染的流行病学、临床意义与诊断
Pathogens. 2025 Mar 7;14(3):262. doi: 10.3390/pathogens14030262.
2
Data-driven, cross-disciplinary collaboration: lessons learned at the largest academic health center in Latin America during the COVID-19 pandemic.数据驱动的跨学科合作:拉丁美洲最大的学术医疗中心在 COVID-19 大流行期间的经验教训。
Front Public Health. 2024 Feb 27;12:1369129. doi: 10.3389/fpubh.2024.1369129. eCollection 2024.

本文引用的文献

1
Viral co-infections among SARS-CoV-2-infected children and infected adult household contacts.新型冠状病毒感染儿童与受感染的成年家庭接触者中的病毒合并感染情况。
Eur J Pediatr. 2021 Jun;180(6):1991-1995. doi: 10.1007/s00431-021-03947-x. Epub 2021 Jan 27.
2
SARS-CoV-2 and Respiratory Syncytial Virus Coinfection in Hospitalized Pediatric Patients.SARS-CoV-2 与呼吸道合胞病毒在住院儿科患者中的合并感染。
Pediatr Infect Dis J. 2021 Apr 1;40(4):e164-e166. doi: 10.1097/INF.0000000000003057.
3
Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study.
比较 COVID-19 和季节性流感的特征、发病率和死亡率:一项全国性、基于人群的回顾性队列研究。
Lancet Respir Med. 2021 Mar;9(3):251-259. doi: 10.1016/S2213-2600(20)30527-0. Epub 2020 Dec 17.
4
COVID-19 and Infant Hospitalizations for Seasonal Respiratory Virus Infections, New Zealand, 2020.2020年新西兰新冠病毒病与季节性呼吸道病毒感染导致的婴儿住院情况
Emerg Infect Dis. 2021 Feb;27(2):641-643. doi: 10.3201/eid2702.204041. Epub 2020 Dec 12.
5
Low impact of SARS-CoV-2 infection among paediatric acute respiratory disease hospitalizations.儿童急性呼吸道疾病住院患者中 SARS-CoV-2 感染的影响较低。
J Infect. 2021 Mar;82(3):414-451. doi: 10.1016/j.jinf.2020.10.013. Epub 2020 Oct 21.
6
Characterizing coinfection in children with COVID-19: A dual center retrospective analysis.新冠病毒感染儿童合并感染情况的特征分析:一项双中心回顾性分析。
Infect Control Hosp Epidemiol. 2021 Sep;42(9):1160-1162. doi: 10.1017/ice.2020.1221. Epub 2020 Sep 23.
7
Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome.儿童 COVID-19 患者和多系统炎症综合征的严重临床谱和高死亡率。
Clinics (Sao Paulo). 2020;75:e2209. doi: 10.6061/clinics/2020/e2209. Epub 2020 Aug 19.
8
Validation and performance comparison of three SARS-CoV-2 antibody assays.三种 SARS-CoV-2 抗体检测试剂盒的验证和性能比较。
J Med Virol. 2021 Feb;93(2):916-923. doi: 10.1002/jmv.26341. Epub 2020 Aug 13.
9
Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series.中国儿童 SARS-CoV-2 感染的临床和流行病学特征:一项多中心病例系列研究。
PLoS Med. 2020 Jun 16;17(6):e1003130. doi: 10.1371/journal.pmed.1003130. eCollection 2020 Jun.
10
Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody.用于特定 SARS-CoV-2 抗体的化学发光测定法的验证。
Clin Chem Lab Med. 2020 Jul 28;58(8):1357-1364. doi: 10.1515/cclm-2020-0594.